Filter
2544
Filtered Results: 2544
Text search:
drug-resistance
infections
Featured
Recommendations
287
New Publications
650
Language
Document type
No document type
1383
Guidelines
422
Studies & Reports
404
Manuals
122
Strategic & Response Plan
91
Fact sheets
44
Training Material
42
Situation Updates
13
Infographics
11
Brochures
4
Resource Platforms
3
App
2
Online Courses
2
Videos
1
Countries / Regions
India
139
Global
80
South Africa
75
Kenya
71
Western and Central Europe
67
Ethiopia
56
Tanzania
44
Uganda
44
Africa
43
Eastern Europe
42
Nepal
41
Nigeria
37
Zambia
37
Latin America and the Carribbean
34
Namibia
32
Liberia
32
Malawi
30
Sierra Leone
29
Ghana
27
Rwanda
26
Asia
25
Bangladesh
25
Myanmar / Burma
25
Philippines
23
South–East Asia Region
22
Cambodia
21
Zimbabwe
18
Lesotho
17
Ukraine
16
Senegal
15
Russia
15
Indonesia
13
Mozambique
12
Cameroon
11
Congo, Democratic Republic of
11
Botswana
10
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Eswatini/ Swaziland
8
Haiti
7
East and Southern Africa
7
Pakistan
7
Colombia
6
China
6
Syria
6
Venezuela
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Argentina
6
Guinea
5
USA
5
Vietnam
5
Georgia
5
Tajikistan
4
Benin
4
Iran
4
Laos
4
Germany
4
Western Pacific Region
4
Brazil
4
Sudan
4
North Macedonia
3
El Salvador
3
Peru
3
Jordan
3
North America
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Iraq
3
Somalia
3
Switzerland
2
Timor Leste/ East Timor
2
Mexico
2
Estonia
2
Afghanistan
2
Morocco
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Uruguay
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Madagascar
2
Guatemala
2
Serbia
1
Turkey
1
Gambia
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Greece
1
Angola
1
Chad
1
Libya
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
891
Clinical Guidelines
269
Public Health
102
Women & Child Health
78
Key Resources
66
Capacity Building
39
Pharmacy & Technologies
34
Annual Report MEDBOX
1
Toolboxes
TB
451
HIV
338
AMR
318
NTDs
115
Malaria
93
COVID-19
83
Mental Health
57
Pharmacy
53
Caregiver
46
Planetary Health
41
Rapid Response
38
Ebola & Marburg
32
Global Health Education
28
Refugee
27
2.0 Rapid Response
21
Health Financing Toolbox
20
NCDs
20
Polio
16
Conflict
13
Cholera
12
Natural Hazards
7
Disability
7
Zika
4
Specific Hazards
3
Social Ethics
1
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
The annual bulletin of the Mekong Malaria Elimination (MME) programme is a yearly report that reviews ongoing efforts to combat multidrug resistance and eliminate malaria in the 6 countries of the Greater Mekong subregion (GMS): Cambodia, China (Yunnan province), Lao People's Democratic Republic, My...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
These are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pa...
The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017.
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ...
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d...
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West...
Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of the burden in these areas is due to infection with P...
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin...
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
WHO has developed this manual in order to strengthen the laboratory diagnosis and virological surveillance of influenza infection.
As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children are at high risk of being infected, STH infection can have a long-term negative impact on their life, i...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Reporting period: January 2014 – December 2014
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in the adult population aged 15 years and older was esti...
The human immunodeficiency virus (HIV) epidemic in Myanmar is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). HIV prevalence in the adult population aged 15 years and older was esti...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
